● Recruiting

Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia

Condition: Rare Diseases · Generalized Myasthenia Gravis (gMG) · Sponsor: AstraZeneca

PhaseN/A

Planned participants450

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is a multicenter, non-interventional, retrospective-prospective, single-arm observational study designed to describe real-world treatment approaches and clinical outcomes among adults with acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (gMG) in routine clinical practice in Russia.

This description comes directly from the study's public registry record.

Talk to the study team

AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com

Always discuss trial participation with your own doctor first.

Locations (7)

Research Site	Kazan', Russia	Recruiting
Research Site	Moscow, Russia	Recruiting
Research Site	Novosibirsk, Russia	Recruiting
Research Site	Rostov-on-Don, Russia	Recruiting
Research Site	Saint Petersburg, Russia	Recruiting
Research Site	Samara, Russia	Recruiting
Research Site	Ufa, Russia	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07247279